Study selection flow diagram. by Laurence Weinberg (2960238)

“…</p><p>Results</p><p>From the initial 1826 articles identified, we included 28 studies from eight countries in a total of 6411 nonagenarians. …”

Inclusion and exclusion criteria. by Laurence Weinberg (2960238)

“…</p><p>Results</p><p>From the initial 1826 articles identified, we included 28 studies from eight countries in a total of 6411 nonagenarians. …”

Key characteristics of the included publications. by Laurence Weinberg (2960238)

“…</p><p>Results</p><p>From the initial 1826 articles identified, we included 28 studies from eight countries in a total of 6411 nonagenarians. …”

Vacancy Engineering Strategy Releases the Electrocatalytic Oxygen Evolution Reaction Activity of High-Entropy Oxides by Boxiong Shen (1557838)

“…The sluggish kinetics of oxygen evolution reaction (OER) poses a great challenge to the industrial promotion of electrocatalytic water splitting and zinc-air battery. Herein, we demonstrate that the kinetic limitation of the OER imposed by a conventional adsorbate evolution mechanism can be successfully overcome through activating lattice oxygen in the electrocatalyst. …”

Vacancy Engineering Strategy Releases the Electrocatalytic Oxygen Evolution Reaction Activity of High-Entropy Oxides by Boxiong Shen (1557838)

“…The sluggish kinetics of oxygen evolution reaction (OER) poses a great challenge to the industrial promotion of electrocatalytic water splitting and zinc-air battery. Herein, we demonstrate that the kinetic limitation of the OER imposed by a conventional adsorbate evolution mechanism can be successfully overcome through activating lattice oxygen in the electrocatalyst. …”

Raw data associated with this manuscript. by Alicer K. Andrew (12269646)

“…This work utilizes experimental murine models of PM (EPM) and CM (ECM) to explore the impact of anticoagulant treatment and tissue-specific or global reduction in TF expression on disease outcomes. In EPM, we show that treatment of wild-type mice with dalteparin, an anticoagulant class that is safe to use in humans during pregnancy, prevented malaria-induced pregnancy loss, significantly improved embryo viability, and decreased placental fibrin deposition at midgestation. …”

Original images for explaining Fig 4. by Reiri Takeuchi (20460788)

“…Treatment with cyclosporine A also increased <i>MYC</i> and <i>ATM</i> mRNA expression levels and decreased <i>CDK2</i>, <i>ATR</i>, <i>P27</i>, <i>P53</i> and <i>RB1</i> mRNA expression levels but not significantly. …”

Enhanced intrinsic excitability of spinal Calcrl⁺ neurons in chronic itch. by Huifeng Jiao (11537806)

“…Data are represented as mean ± SEM (n = 5 mice per group). ns: not significant, *p < 0.05, **p < 0.01. …”

The <i>ENT2</i> knockout effects on CRC proliferation and survival. by Safaa M. Naes (22075434)

“…Data are presented as means ± SD and expressed as % relative to control cells. * indicates a significant difference between NTC vs. …”

This figure illustrates the impact of <i>Lactobacillus reuteri</i> supplementation on key indicators of colitis induced by dextran sulfate sodium (DSS). by Mohsen Nazari (6299819)

“…The data are expressed as mean ± standard deviation (SD) for three biological replicates (n = 8). …”

TSA alleviates the induction of inflammatory cytokines in <i>Col4a3</i> KO mice. by Yoon Seok Nam (20678482)

“…(C) TSA treatment significantly decreased IL-6, IL1β, TNF-α, and TGF-β1 protein levels in HEI-OC1 cells (n = 7). …”

Minigene assay of rare missense VUS in exon 10. by Elina Mercier (22311151)

“…All of the tested variants significantly increase exon 10 skipping except for c.1061T > C; p.Leu354Pro which decreased skipping. …”

Effects of Semaglutide and Dapagliflozin on Neuronal Integrity, Apoptosis, and LRP1 Expression in the Hippocampal CA1 Region of T2DM Mice. by Yan Zhu (112437)

“…(D) Quantitative analysis of LRP1 expression shows significantly decreased levels in the T2DM group compared to control (***<i>p</i> < 0.001), while both semaglutide and da<i>p</i>agliflozin treatment significantly restored LRP1 expression compared to the T2DM group (***<i>p</i> < 0.001). …”

Primer sequences. by Koichi Yoshimoto (9298643)

“…We examined the mRNA expression of <i>Ddit3</i> (CHOP) and <i>Casp3</i> (caspase-3) on day one after the surgery; mRNA expression of both genes appeared to decrease in the KUS121 group, as compared with the control group, although differences between groups were not significant. …”

Identification of VHL as a novel E3 ubiquitin ligase for Vpx. by Kei Miyakawa (255697)

“…Data are presented as mean ± standard deviation (SD) (n = 2). Statistical significance was evaluated using a two-tailed unpaired <i>t</i>-test. …”

Functional and strength parameters. by Susanne S. Rauh (21192252)

“…An overall tendency to an increase in FF and a decrease in functional measures were observed over 2 years. …”

Tailoring Ionic Conductivity of Polymeric Ionic Liquid Block Copolymers through Morphology Control by Samuel K. J. Adotey (22425591)

“…We further show that transport-blocking defects are largely absent from PIL-rich morphologies having nonionic cylindrical or spherical domains embedded in a PIL matrix. …”

Defect-Triggered Reversible Phase Transformation for Boosting Electrochemical Performance of Coordination Polymers by Yixiu Xu (11166860)

“…Contrary to this common sense, here we demonstrate that both implanting defects and eliminating defects can significantly boost the specific capacitance of the defect-engineered CPs (DECPs), which are about 1.23 and 1.62 times that of the pristine CP, respectively, without loss of rate capability even after 10,000 charge–discharge cycles. …”

Raw data underlying the findings in this study. by Andrew Mvula (20161161)

“…The relative bone density significantly decreased as standard length and condition factor (<i>K</i>) increased in both sexes. …”

Defect-Triggered Reversible Phase Transformation for Boosting Electrochemical Performance of Coordination Polymers by Yixiu Xu (11166860)

“…Contrary to this common sense, here we demonstrate that both implanting defects and eliminating defects can significantly boost the specific capacitance of the defect-engineered CPs (DECPs), which are about 1.23 and 1.62 times that of the pristine CP, respectively, without loss of rate capability even after 10,000 charge–discharge cycles. …”